In the realm of in vitro inhalation research, precision and reliability are paramount. The recent OECD – OCDE Case Study No. 367 demonstrates how VITROCELL’s technology is at the forefront of advancing respiratory health research.
Cutting-Edge Exposure Systems: Our in vitro exposure systems, are extensively utilized to simulate realistic conditions for testing the impact of aerosolized substances on human respiratory tissues. This allows researchers to closely mimic human exposure environments, providing critical insights into the health effects of inhaled substances.
Enabling Advanced Research: The study showcases the versatility of our exposure systems and their crucial role in pioneering research that can lead to enhanced research outcomes and product safety without the use of laboratory animals.
Supporting Regulatory Compliance: By facilitating detailed and accurate exposure assessments, our technologies help streamline the path to regulatory approval, ensuring that products meet the highest safety standards before reaching the market.
If you are currently engaged in an OECD or other validation, conducting a case study, or aware of another OECD recommendation concerning in vitro inhalation, please reach out to Patricia Hebestreit (p.hebestreit@vitrocell.com).
